Zhai Yingjiao, Zhang Yu, Liu Fujun, Fang Wenhui, Li Jinhua, Xu Mingze, Chen Shuming, Zeng Hao
Ministry of Education Key Laboratory for Cross-Scale Micro and Nano Manufacturing, Nanophotonics and Biophotonics Key Laboratory of Jilin Province, Changchun University of Science and Technology, Changchun, 130022, PR China.
Ministry of Education Key Laboratory for Cross-Scale Micro and Nano Manufacturing, Nanophotonics and Biophotonics Key Laboratory of Jilin Province, Changchun University of Science and Technology, Changchun, 130022, PR China.
Talanta. 2026 Jan 1;296:128420. doi: 10.1016/j.talanta.2025.128420. Epub 2025 Jun 2.
Colorimetric/surface-enhanced Raman scattering (SERS) dual-mode detection offers richer detection information and higher accuracy. However, achieving "non-enzymatic" one-step catalytic colorimetric/SERS glucose detection using molybdenum disulfide (MoS)-based nanozymes remains challenging. Here, we propose a tandem enzyme system, BAMC, composed of bovine serum albumin-modified gold nanoparticles (BSA@Au) integrated with carboxylated molybdenum disulfide (MoS-COOH). This approach overcomes the inhibition of glucose oxidase (GOx)-like activity caused by Au-S bonding, enabling dual-mode colorimetric/SERS glucose detection with detection limits (LOD) of 10 M and 10 M, respectively. For non-invasive glucose detection, the BAMC system demonstrated excellent stability in saliva and urine samples. The results were highly consistent with commercial glucose detection methods, with errors controlled at 19.67 % and 6.66 %, meeting the World Health Organization 's standard of less than 20 % error for glucometers. The BAMC system offers a novel approach for non-invasive glucose detection and paves the way for developing other nanozymes.
比色/表面增强拉曼散射(SERS)双模式检测提供了更丰富的检测信息和更高的准确性。然而,使用基于二硫化钼(MoS)的纳米酶实现“非酶促”一步催化比色/SERS葡萄糖检测仍然具有挑战性。在此,我们提出了一种串联酶系统BAMC,它由与羧基化二硫化钼(MoS-COOH)整合的牛血清白蛋白修饰的金纳米颗粒(BSA@Au)组成。这种方法克服了由金硫键引起的对葡萄糖氧化酶(GOx)样活性的抑制,实现了比色/SERS双模式葡萄糖检测,检测限(LOD)分别为10 M和10 M。对于无创葡萄糖检测,BAMC系统在唾液和尿液样本中表现出优异的稳定性。结果与商业葡萄糖检测方法高度一致,误差分别控制在19.67%和6.66%,符合世界卫生组织血糖仪误差小于20%的标准。BAMC系统为无创葡萄糖检测提供了一种新方法,并为开发其他纳米酶铺平了道路。